Search research articles
Contact Us
Filters
Showing results (321-330 of 347) with videos related to
Page
of 35
Sort By:
European Journal of Clinical Investigation
|
November 16, 2022
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial
Alessia Ferrarini, Angelo Vacca, Antonio Giovanni Solimando, et al.
Journal of Clinical Medicine
|
July 21, 2019
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment
Antonio Giovanni Solimando, Matteo Claudio Da Vià, Sebastiano Cicco, et al.
Journal of Clinical Medicine
|
September 13, 2025
The LUNET Project: Developing the Italian Systemic Erythematous Lupus Network
Ilaria Mormile, Luisa Brussino, Giorgio Walter Canonica, et al.
European Journal of Medicinal Chemistry
|
December 28, 2018
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability
Maria Laura Pati, Paola Vitale, Savina Ferorelli, et al.
The Journal of Pathology
|
October 26, 2018
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes
Maria Antonia Frassanito, Vanessa Desantis, Lucia Di Marzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2011
Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma
Annunziata De Luisi, Arianna Ferrucci, Addolorata M L Coluccia, et al.
International Journal of Immunopathology and Pharmacology
|
December 9, 2016
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
Clementina Canessa, Jessica Iacopelli, Antonio Pecoraro, et al.
Frontiers in Immunology
|
March 29, 2021
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers
Francesco Cinetto, Riccardo Scarpa, Maria Carrabba, et al.
Journal of Hematology & Oncology
|
January 11, 2019
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial
Ilaria Saltarella, Fortunato Morabito, Nicola Giuliani, et al.
Journal of Clinical Immunology
|
April 21, 2022
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)
Giuliana Giardino, Cinzia Milito, Vassilios Lougaris, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 347) with videos related to
Sort By:
Page
of 35
European Journal of Clinical Investigation
|
November 16, 2022
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial
Alessia Ferrarini, Angelo Vacca, Antonio Giovanni Solimando, et al.
Journal of Clinical Medicine
|
July 21, 2019
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment
Antonio Giovanni Solimando, Matteo Claudio Da Vià, Sebastiano Cicco, et al.
Journal of Clinical Medicine
|
September 13, 2025
The LUNET Project: Developing the Italian Systemic Erythematous Lupus Network
Ilaria Mormile, Luisa Brussino, Giorgio Walter Canonica, et al.
European Journal of Medicinal Chemistry
|
December 28, 2018
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability
Maria Laura Pati, Paola Vitale, Savina Ferorelli, et al.
The Journal of Pathology
|
October 26, 2018
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes
Maria Antonia Frassanito, Vanessa Desantis, Lucia Di Marzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2011
Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma
Annunziata De Luisi, Arianna Ferrucci, Addolorata M L Coluccia, et al.
International Journal of Immunopathology and Pharmacology
|
December 9, 2016
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
Clementina Canessa, Jessica Iacopelli, Antonio Pecoraro, et al.
Frontiers in Immunology
|
March 29, 2021
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers
Francesco Cinetto, Riccardo Scarpa, Maria Carrabba, et al.
Journal of Hematology & Oncology
|
January 11, 2019
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial
Ilaria Saltarella, Fortunato Morabito, Nicola Giuliani, et al.
Journal of Clinical Immunology
|
April 21, 2022
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)
Giuliana Giardino, Cinzia Milito, Vassilios Lougaris, et al.
Page
of 35